BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$414M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$371M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$342M |
| 4 |
Microsoft
MSFT
|
+$339M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Salesforce
CRM
|
+$688M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$338M |
| 4 |
Eli Lilly
LLY
|
+$239M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.86% |
| 2 | Consumer Discretionary | 6.16% |
| 3 | Healthcare | 5.91% |
| 4 | Communication Services | 5.19% |
| 5 | Financials | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Eagle Bancorp
EGBN
$878M
| $86.6K | ﹤0.01% |
2,643
-11,250
| -81% | -$359K |
|
|
FBC
2677
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $86.6K | ﹤0.01% |
2,941
-12,664
| -81% | -$324K |
|
2678
City Holding Co
CHCO
$2.07B
| $86.5K | ﹤0.01% |
1,327
-5,398
| -80% | -$342K |
|
|
NAV
2679
DELISTED
Navistar International
NAV
| $86.2K | ﹤0.01% |
3,057
-13,397
| -81% | -$318K |
|
|
EGRX
2680
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $86K | ﹤0.01% |
1,793
-20,193
| -92% | -$1.01M |
|
2681
State Street SPDR S&P Pharmaceuticals ETF
XPH
$518M
| $86K | ﹤0.01% |
+2,000
| New | +$82.7K |
|
2682
Universal Corp
UVV
$1.11B
| $85.8K | ﹤0.01% |
2,019
-8,488
| -81% | -$373K |
|
|
BHR
2683
Braemar Hotels & Resorts
BHR
$139M
| $85.7K | ﹤0.01% |
29,967
+20,713
| +224% | +$60.1K |
|
2684
Vericel Corp
VCEL
$2.26B
| $85.7K | ﹤0.01% |
6,200
-15,497
| -71% | -$210K |
|
2685
McGrath RentCorp
MGRC
$2.99B
| $85.7K | ﹤0.01% |
1,586
-6,461
| -80% | -$347K |
|
|
WIRE
2686
DELISTED
Encore Wire Corp
WIRE
| $85.6K | ﹤0.01% |
1,754
-6,887
| -80% | -$316K |
|
2687
Hilltop Holdings
HTH
$2.27B
| $85.6K | ﹤0.01% |
4,637
-20,493
| -82% | -$352K |
|
2688
WesBanco
WSBC
$4.09B
| $85.5K | ﹤0.01% |
4,209
-50,402
| -92% | -$1.1M |
|
2689
Arcus Biosciences
RCUS
$3.75B
| $85.4K | ﹤0.01% |
3,453
-6,574
| -66% | -$177K |
|
2690
Employers Holdings
EIG
$875M
| $85.4K | ﹤0.01% |
2,832
-11,228
| -80% | -$346K |
|
|
PRA
2691
DELISTED
ProAssurance
PRA
| $85K | ﹤0.01% |
5,872
-16,721
| -74% | -$287K |
|
|
LTHM
2692
DELISTED
Livent Corporation
LTHM
| $85K | ﹤0.01% |
13,792
-48,133
| -78% | -$303K |
|
|
FOE
2693
DELISTED
Ferro Corporation
FOE
| $84.5K | ﹤0.01% |
7,081
-27,306
| -79% | -$293K |
|
2694
OFG Bancorp
OFG
$2.28B
| $83.9K | ﹤0.01% |
6,278
-20,266
| -76% | -$244K |
|
2695
Encore Capital Group
ECPG
$2.2B
| $83.8K | ﹤0.01% |
2,453
-10,192
| -81% | -$304K |
|
|
WDR
2696
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $83.7K | ﹤0.01% |
5,397
-28,240
| -84% | -$387K |
|
2697
Astec Industries
ASTE
$997M
| $83.6K | ﹤0.01% |
1,806
-7,611
| -81% | -$312K |
|
2698
cbdMD
YCBD
$5.2M
| $83.6K | ﹤0.01% |
122
+106
| +663% | +$47.6K |
|
2699
Verra Mobility
VRRM
$717M
| $83.5K | ﹤0.01% |
8,119
-36,087
| -82% | -$342K |
|
|
AZUL
2700
DELISTED
Azul
AZUL
| $83.3K | ﹤0.01% |
7,455
+784
| +12% | +$7.54K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2020 Portfolio in Review
As of Q2 2020, BNP Paribas Financial Markets held 4,480 positions worth $56.7B, up 16% from $48.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets withdrew a net $2.34B in Q2 2020, closing 174 positions and reducing 2,678 holdings. Its most notable exit was Allergan plc, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in State Street SPDR Portfolio Intermediate Term Corporate Bond ETF worth $35.2M.
- BNP Paribas Financial Markets's largest Q2 2020 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 962,483 shares worth $35.2M.
- BNP Paribas Financial Markets added most to Apple in Q2 2020, an estimated $414M increase.
- BNP Paribas Financial Markets's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2020, selling an estimated $225M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $56.7B portfolio in Q2 2020.
- BNP Paribas Financial Markets opened 164 new positions and closed 174 in Q2 2020.
- BNP Paribas Financial Markets's portfolio value rose 16% quarter-over-quarter to $56.7B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.